Medtronic’s Diabetes Split-Off Drew a Crowd. Now MiniMed Has to Deliver
Twin Cities Business
Medtronic’s recent spin-off of its diabetes business, creating a standalone MiniMed, attracted significant attention. Now, the focus shifts to MiniMed’s ability to deliver on the promise of this separation.
As previously mentioned, the split was seen as a testament to Medtronic’s growth and its commitment to focusing on core areas. However, it also brings new challenges for MiniMed, especially in navigating the competitive market.
In light of the above, the success of MiniMed will be measured by its ability to enhance and deliver innovative diabetes solutions, ensuring it remains a game changer in the industry.